Two healthcare start-ups, HearX Group from South Africa and Lapaire from Ivory Coast, are making strides in addressing fundamental health needs on the continent. By focusing on hearing and vision solutions, these companies showcase innovation and impact in the African health sector, reflecting a shift towards accessible healthcare post-pandemic.
Healthcare Start-ups Address Hearing and Vision Needs in Africa
Two healthcare start-ups, South Africa’s HearX Group and Lapaire from Ivory Coast, have emerged as notable entities by focusing on fundamental health needs in Africa: hearing and sight. These companies were ranked 10th and 14th, respectively, in the FT/Statista list of high-growth companies, reflecting their impact and innovation in the health sector.
HearX Group: Founded by Nic Klopper and colleagues, HearX Group was initiated after the realization that affordable hearing tests and hearing aid equipment were inaccessible to many. Using AI technology from Pretoria University, HearX transformed the traditional audiometer into a smartphone-compatible device. This innovation, however, contributed only 5% to their revenue.
The significant breakthrough came with the development of over-the-counter hearing aids, benefiting from a 2022 legislation change in the US. These aids, retailing at $999, are connected to smartphones via Bluetooth, allowing users to adjust them with an app and consult HearX specialists remotely. HearX reported $58 million in sales in 2023 and aims to expand into new markets, including a pilot in Kenya.
Lapaire: Jérôme Lapaire, a Swiss lawyer based in Nairobi, noticed a lack of affordable eyewear among the general population. He started by purchasing low-cost glasses online and offering vision tests at companies. After initial setbacks in East Africa, Lapaire shifted focus to West Africa and now has 70 retail outlets in six countries, including Ivory Coast and Uganda.
Lapaire’s glasses, priced between $35 and $50, are sourced from factories in China, Tunisia, and Japan. Despite facing challenges such as currency depreciation and lack of insurance coverage for customers, the company has found market acceptance in West Africa. Lapaire raised $3 million in recent funding and is positioned for growth by targeting uninsured individuals.
These companies underline a trend towards addressing basic healthcare needs with innovative and accessible solutions, reflecting a broader shift in Africa’s healthcare landscape post-pandemic.
